Skandinaviska Enskilda Banken (SEB)’s Avanos Medical AVNS Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Buy	+5,000	New	+$117K	﹤0.01%	143
2024 Q1	–	Sell	-45,600	Closed	-$1.02M	–	804
2023 Q4	$1.02M	Hold	45,600	–	–	0.01%	694
2023 Q3	$922K	Sell	45,600 -9,400	-17%	-$213K	0.01%	687
2023 Q2	$1.41M	Buy	55,000 +7,600	+16%	+$200K	0.01%	636
2023 Q1	$1.41M	Buy	+47,400	New	+$1.38M	0.01%	629
2022 Q3	–	Sell	-13,476	Closed	-$368K	–	902
2022 Q2	$368K	Sell	13,476 -2,568	-16%	-$73.8K	﹤0.01%	846
2022 Q1	$537K	Sell	16,044 -7,963	-33%	-$256K	﹤0.01%	826
2021 Q4	$828K	Hold	24,007	–	–	﹤0.01%	795
2021 Q3	$749K	Buy	24,007 +22,426	+1,418%	+$761K	﹤0.01%	829
2021 Q2	$58K	Hold	1,581	–	–	﹤0.01%	1004
2021 Q1	$69K	Hold	1,581	–	–	﹤0.01%	1065
2020 Q4	$73K	Hold	1,581	–	–	﹤0.01%	1067
2020 Q3	$53K	Hold	1,581	–	–	﹤0.01%	967
2020 Q2	$46K	Hold	1,581	–	–	﹤0.01%	994
2020 Q1	$43K	Hold	1,581	–	–	﹤0.01%	882
2019 Q4	$53K	Hold	1,581	–	–	﹤0.01%	893
2019 Q3	$59K	Hold	1,581	–	–	﹤0.01%	873
2019 Q2	$69K	Buy	+1,581	New	+$67.6K	﹤0.01%	801

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SRC

Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

TMAM

Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return

KIM

Kestrel Investment Management San Mateo, California $184M AUM 31.66% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s AVNS Position: Q2 2026 in Review

Skandinaviska Enskilda Banken (SEB) opened a new position in Avanos Medical (AVNS) in Q2 2026: 5,000 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #143 among its holdings. This is a return to the name: Skandinaviska Enskilda Banken (SEB) previously reported a position in AVNS as recently as Q4 2023.

Skandinaviska Enskilda Banken (SEB) first reported a position in AVNS in Q2 2019 and has held it in 18 quarters since. The position peaked at $1.41M in Q1 2023. 146 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Skandinaviska Enskilda Banken (SEB) held 5,000 shares of Avanos Medical worth $124K as of Q2 2026.
Avanos Medical was a new Skandinaviska Enskilda Banken (SEB) position in Q2 2026.
Avanos Medical made up ﹤0.01% of Skandinaviska Enskilda Banken (SEB)'s portfolio in Q2 2026, its #143 holding.
Skandinaviska Enskilda Banken (SEB) first reported a position in Avanos Medical in Q2 2019 and has held it in 18 quarters since.
Skandinaviska Enskilda Banken (SEB)'s Avanos Medical position peaked at $1.41M in Q1 2023.
146 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2026, filed 10 Aug 2026.